FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4128711000001106: Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21863501000001117 Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21863601000001118 Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Is pack of Tetracosactrin 250micrograms/1mL injection false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient Pituitary hormone false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient Tetracosactide false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient Tetracosactide acetate false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has VMP Tetracosactrin 250micrograms/1mL injection false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has specific active ingredient Tetracosactide acetate false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has specific active ingredient Tetracosactide acetate true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has VMP Tetracosactide 250micrograms/1ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has VMP Tetracosactide 250micrograms/1ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 5 ampoule Is a True Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start